Ensysce Biosciences (ENSC) EBIT Margin (2020 - 2025)
Ensysce Biosciences' EBIT Margin came in at -758.68% for Q3 2025, down 777.54 percentage points from 18.86% a year earlier and down 631.04 percentage points from the prior quarter.
Powered by 
Analysis
Ensysce Biosciences (ENSC) EBIT Margin (2020 - 2025) Analysis & Trends
Over the trailing twelve months to Sep 30, 2025, Ensysce Biosciences reported EBIT Margin of -245.89%, down 103.19 percentage points year-over-year; for FY2024, it came in at -129.18%, up 351.35 percentage points from FY2023.
- EBIT Margin carries a four-year change of -88.14 percentage points (FY2020 to FY2024).
- Going back by year, EBIT Margin was -480.52% in FY2023 (+479.38 pp), -959.91% in FY2022 (-397.20 pp), -562.71% in FY2021 (-521.67 pp) and -41.04% in FY2020.
- The Q3 2025 figure represents the lowest quarterly EBIT Margin since Q2 2024.
- Year-over-year, EBIT Margin increased in four of the last eight quarters, with an average year-over-year change of +67.09 percentage points.
- The fastest year-over-year change in EBIT Margin over five years came in Q2 2023 (a gain of 2932.86 percentage points), and the weakest in Q2 2022 (a drop of 3307.74 percentage points).
- Business Quant data shows ENSC's EBIT Margin at -127.64% (Q2 2025), -149.08% (Q1 2025) and -274.34% (Q4 2024) in the three quarters before Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 37.40% |
| 10 | Ensysce Biosciences | 1.02 Mn | -10.55 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -758.68% |
| Jun 30, 2025 | -127.64% |
| Mar 31, 2025 | -149.08% |
| Dec 31, 2024 | -274.34% |
| Sep 30, 2024 | 18.86% |
| Jun 30, 2024 | -1,075.62% |
| Mar 31, 2024 | -602.82% |
| Dec 31, 2023 | -612.72% |
| Sep 30, 2023 | -621.83% |
| Jun 30, 2023 | -467.70% |
| Mar 31, 2023 | -324.36% |
| Dec 31, 2022 | -432.57% |
| Sep 30, 2022 | -2,206.30% |
| Jun 30, 2022 | -3,400.56% |
| Mar 31, 2022 | -796.36% |
| Dec 31, 2021 | -122.71% |
| Sep 30, 2021 | -1,406.28% |
| Jun 30, 2021 | -92.82% |
| Mar 31, 2021 | -209.23% |
| Dec 31, 2020 | -262.51% |
API Access
Ensysce Biosciences EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=ENSC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "ENSC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=ENSC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();